321 related articles for article (PubMed ID: 12351411)
1. Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis.
Testa U; Riccioni R; Militi S; Coccia E; Stellacci E; Samoggia P; Latagliata R; Mariani G; Rossini A; Battistini A; Lo-Coco F; Peschle C
Blood; 2002 Oct; 100(8):2980-8. PubMed ID: 12351411
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of IL-3Rα on CD34+CD38- stem cells defines leukemia-initiating cells in Fanconi anemia AML.
Du W; Li XE; Sipple J; Pang Q
Blood; 2011 Apr; 117(16):4243-52. PubMed ID: 21330473
[TBL] [Abstract][Full Text] [Related]
3. Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient mice.
Yalcintepe L; Frankel AE; Hogge DE
Blood; 2006 Nov; 108(10):3530-7. PubMed ID: 16882709
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic features of acute myeloid leukemias overexpressing the interleukin 3 receptor alpha chain.
Riccioni R; Rossini A; Calabrò L; Diverio D; Pasquini L; Lococo F; Peschle C; Testa U
Leuk Lymphoma; 2004 Aug; 45(8):1511-7. PubMed ID: 15370201
[TBL] [Abstract][Full Text] [Related]
5. Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34- blasts from acute myelogenous leukemia.
Akashi K; Harada M; Shibuya T; Eto T; Takamatsu Y; Teshima T; Niho Y
Blood; 1991 Jul; 78(1):197-204. PubMed ID: 1712640
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-3 receptor in acute leukemia.
Testa U; Riccioni R; Diverio D; Rossini A; Lo Coco F; Peschle C
Leukemia; 2004 Feb; 18(2):219-26. PubMed ID: 14671644
[TBL] [Abstract][Full Text] [Related]
7. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
8. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Relevance of Cytokine Receptor Expression in Acute Myeloid Leukemia: Interleukin-2 Receptor α-Chain (CD25) Expression Predicts a Poor Prognosis.
Nakase K; Kita K; Kyo T; Ueda T; Tanaka I; Katayama N
PLoS One; 2015; 10(9):e0128998. PubMed ID: 26375984
[TBL] [Abstract][Full Text] [Related]
10. Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor.
Riccioni R; Diverio D; Riti V; Buffolino S; Mariani G; Boe A; Cedrone M; Ottone T; Foà R; Testa U
Br J Haematol; 2009 Feb; 144(3):376-87. PubMed ID: 19036083
[TBL] [Abstract][Full Text] [Related]
11. Effect of thrombopoietin on acute myelogenous leukemia blasts.
Tokunaga Y; Miyamoto T; Gondo H; Okamura T; Niho Y
Leuk Lymphoma; 2000 Mar; 37(1-2):27-37. PubMed ID: 10721767
[TBL] [Abstract][Full Text] [Related]
12. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 production by the blast cells of acute myeloblastic leukemia: regulation by endogenous interleukin-1 and biological implications.
Beauchemin V; Villeneuve L; Rodriguez-Cimadevilla JC; Rajotte D; Kenney JS; Clark SC; Hoang T
J Cell Physiol; 1991 Sep; 148(3):353-61. PubMed ID: 1918169
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.
Cross AH; Goorha RM; Nuss R; Behm FG; Murphy SB; Kalwinsky DK; Raimondi S; Kitchingman GR; Mirro J
Blood; 1988 Aug; 72(2):579-87. PubMed ID: 3261183
[TBL] [Abstract][Full Text] [Related]
15. Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia.
Bruserud O; Tore Gjertsen B; Brustugun OT; Bassøe CF; Nesthus I; Espen Akselsen P; Bühring HJ; Pawelec G
Leukemia; 1995 Nov; 9(11):1910-20. PubMed ID: 7475283
[TBL] [Abstract][Full Text] [Related]
16. Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses.
van Luijn MM; Chamuleau ME; Thompson JA; Ostrand-Rosenberg S; Westers TM; Souwer Y; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Haematologica; 2010 Mar; 95(3):485-93. PubMed ID: 19903675
[TBL] [Abstract][Full Text] [Related]
17. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
Bruserud O; Ulvestad E
J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
[TBL] [Abstract][Full Text] [Related]
18. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
19. Diphtheria toxin fused to variant human interleukin-3 induces cytotoxicity of blasts from patients with acute myeloid leukemia according to the level of interleukin-3 receptor expression.
Testa U; Riccioni R; Biffoni M; Diverio D; Lo-Coco F; Foà R; Peschle C; Frankel AE
Blood; 2005 Oct; 106(7):2527-9. PubMed ID: 15928038
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
